Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Editorial board
The Publisher
Abstracting and indexing
Publication ethics
Privacy Statement
Contact
Policies
Open access policy
Editorial policies
Authors' self archiving and sharing policy
Commercial policies
Privacy policy
Guidelines
Guidelines for authors
Guidelines for Reviewers
Artwork guidelines
Publication fees
Archives
Current
Search
Register
Login
Submit now
Home
/
Archives
/
Vol. 3 No. 2 (2016): May-August 2016
Vol. 3 No. 2 (2016): May-August 2016
Published:
2016-08-31
Original Research Articles
An Approach to Evaluate Payment-by-Results Agreements
Un approccio alla valutazione degli accordi negoziali “payment-by-results”
Clement Tournier, Valerie Deroo, Sara Villa, Giovanni Giuliani, Carlo Lucioni, Silvio Mazzi, Roberto Ravasio
57-61
PDF
On the New Payment-by-Results Method for Determining the Fair Price of New Drugs. An Application in Oncology
Sul nuovo metodo di payment-by-results per la determinazione del prezzo equo dei nuovi farmaci. Un'applicazione in Oncologia
Enzo Ballatori, Salvatore Palazzo, Benedetta Ruggeri, Donatella Morale, Aldo Filice, Carmela Oriolo, Alberto Vergati, Marianna Napoletano, Isidoro Mazzoni
62-66
PDF
Economic Evaluation of Ipilimumab in First Line Treatment of Advanced Melanoma in Italy
Maria De Francesco, Mark Lamotte, Paolo Antonio Ascierto, Paolo Di Rienzo, Yumi Asukai
67-79
PDF
Therapeutic Strategies and Health Costs of Patients Admitted for a Cardiovascular Event in Italy
Percorsi terapeutici e costi sanitari di pazienti ricoverati per un evento cardiovascolare in Italia
Carlo Lucioni, Silvio Mazzi, Elisa Rossi, Rita Rielli, Silvia Calabria, Aldo Pietro Maggioni
80-91
PDF
Economic Evaluation of Canagliflozin versus Glimepiride and Sitagliptin in Dual Therapy with Metformin for the Treatment of Type 2 Diabetes in Italy
Roberto Ravasio, Patrizia Pisarra, Roberto Porzio, Marco Comaschi
92-101
PDF
Costs of Tiotropium Bromide Delivered via the Respimat® Inhaler in COPD Patients in Italy
Il costo del trattamento della BPCO in Italia mediante l'uso di tiotropio bromuro somministrato tramite l'inalatore Respimat®
Sergio Iannazzo, Chiara Distante, Angelo Guido Corsico
102-109
PDF
Economic Evaluation of Nevirapine plus Raltegravir as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1 Infected Patients
Valutazione economica della combinazione nevirapina/raltegravir quale terapia antiretrovirale di mantenimento nei pazienti con infezione da HIV-1 in soppressione virologica
Roberto Ravasio, Fabio Rigo, Emanuela Lattuada, Ercole Concia, Massimiliano Lanzafame
110-114
PDF
Sign up
Browse
Categories
Health Technology Assessment
Health Policies
banners150
Completed peer reviews since:
November 4, 2020